BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23280570)

  • 1. Different indications, warnings and precautions, and contraindications for the same drug--an international comparison of prescribing information for commonly used psychiatric drugs.
    Pfistermeister B; Schenk C; Kornhuber J; Bürkle T; Fromm MF; Maas R
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):329-33. PubMed ID: 23280570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the editor-caution urged in prescribing psychotropic drugs for older patients.
    Thomas SP
    Issues Ment Health Nurs; 2005 May; 26(4):357-8. PubMed ID: 16020053
    [No Abstract]   [Full Text] [Related]  

  • 3. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA drug prescribing warnings: is the black box half empty or half full?
    Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety information in drug labeling: a comparison of the USA, the UK, and Japan.
    Shimazawa R; Ikeda M
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):306-18. PubMed ID: 23355452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial.
    Martens JD; Winkens RA; van der Weijden T; de Bruyn D; Severens JL
    BMC Health Serv Res; 2006 Nov; 6():145. PubMed ID: 17081285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of indicators assessing the quality of drug prescribing for asthma.
    Veninga CC; Denig P; Pont LG; Haaijer-Ruskamp FM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):143-61. PubMed ID: 11324741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.
    Kesselheim AS; Franklin JM; Avorn J; Duke JD
    BMJ Qual Saf; 2013 Sep; 22(9):727-34. PubMed ID: 23620531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
    Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency in the safety labeling of bioequivalent medications.
    Duke J; Friedlin J; Li X
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):294-301. PubMed ID: 23042584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of psychotropic drug use during pregnancy: a review.
    Einarson A
    MedGenMed; 2005 Oct; 7(4):3. PubMed ID: 16614625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of implementing alerts about medication black-box warnings in electronic health records.
    Yu DT; Seger DL; Lasser KE; Karson AS; Fiskio JM; Seger AC; Bates DW
    Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):192-202. PubMed ID: 21254291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.
    Lipworth W; Kerridge I; Brett J; Day R
    BMJ; 2011 Dec; 343():d7459. PubMed ID: 22134968
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug utilisation 90% profiles--a useful tool for quality assessment of prescribing in primary health care in Stockholm.
    Wettermark B; Pehrsson A; Jinnerot D; Bergman U
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):499-510. PubMed ID: 14521137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irish Medicines Board safety warnings: do they affect prescribing rates in primary care?
    Musleh S; Kraus S; Bennett K; Zaharan NL
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):979-86. PubMed ID: 21774032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of drug use in Jordan using WHO prescribing indicators.
    Otoom S; Batieha A; Hadidi H; Hasan M; Al-Saudi K
    East Mediterr Health J; 2002; 8(4-5):537-43. PubMed ID: 15603035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some current factors influencing the prescribing and use of psychiatric drugs.
    Poulsen RL
    Public Health Rep; 1992; 107(1):47-53. PubMed ID: 1738808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.